Although there are a full range of tools available to countries who wish to increase access to healthcare, compulsory licensing has been described by some as the preferential tool for access. Increasingly countries are looking to compulsory licensing as a tool to gain access to medicines where no public health emergency or similar circumstances exist. A panel of experts will look at various approaches and considerations related to increasing access to medicines, including compulsory licensing. The panel will also look at the economic, investment and access consequences of using compulsory licenses, including countries that have and have not made use of this option as examples.
Ability Level: All
Session ID: 2112